Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 18 February 2021 to 19 March 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Potassium hydrogen fluoride, reaction product with boric acid and dipotassium salt of boric acid
- Cas Number:
- 2787482-26-0
- Molecular formula:
- not applicable (UVCB)
- IUPAC Name:
- Potassium hydrogen fluoride, reaction product with boric acid and dipotassium salt of boric acid
- Test material form:
- solid - liquid: suspension
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- - Source: Institute of Experimental Pharmacology and Toxicology, Center of
Experimental Medicine of the Slovak Academy of Sciences, Dobrá
Voda, Slovak Republic
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: 8-12 weeks
- Housing: The animals were housed in plastic cages suspended on stainless steel
racks, up to 3 animals per cage, in a room equipped with central airconditioning.
The room temperature was maintained within the range of
22±2 °C. The relative humidity will be 55±10 %. The light regime was
set to a 12-hour light / 12-hour dark cycle. The sanitation was performed
according to standard operation procedures. For bedding AlpenSpan Eco, Johann Pabst Holzindustrie GmbH, Zeltweg, Austria was used
- Diet (e.g. ad libitum): A standard laboratory food KKZ-P/M (UEFT CEM SAS) was available
ad libitum. Animals were fasted prior to dosing.
- Water (e.g. ad libitum): The animals received tap water for human consumption. Supply of
drinking water was unlimited. The quality of drinking water is periodical
monitored (including microbiological control) and recorded
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:
- Amount of vehicle (if gavage):
- Justification for choice of vehicle: Ultra pure water such as API is a common vehicle for water soluble items in toxicity studies like OECD TG 423
- Lot/batch no. (if required): 19L1001
- Purity:
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Available information indicated that the test item was likely to be non-toxic regarding acute toxicity therefore we chose a dose of 2000 mg of 3A-Flux per kg body weight to be used as a starting dose. - Doses:
- 2000 mg/kg bw
300 mg/kg bw - No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: Immediately after the administration of the test item and then
0.5, 1, 2 and 4 hours later and daily afterwards
- Frequency of weighing: Before administration and weekly thereafter
- Necropsy of survivors performed: All animals were subject to gross necropsy
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: LD50 between 300 mg/kg bw and 2000 mg/kg bw
- Mortality:
- Mortality of 3/3 females at limit dose of 2000 mg/kg body weight was observed.
- Clinical signs:
- lethargy (hypoactivity)
- sleep
- other: Depression of CNS
- Body weight:
- other body weight observations
- Remarks:
- No effects observed
- Gross pathology:
- For animals treated with 2000 mg/kg bw ulcerative lesions in small intestine were observed.
No observations in animal treated with 300 mg/kg bw.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 of the test item 3A-Flux is greater than 300 mg/kg and lower than 2000 mg/kg body weight after single oral administration to Wistar rats.
Based on Annex 2d Test Procedure with a Starting Dose of 2000 mg/kg body weight of OECD Guideline 423 it can be concluded that the test item 3A-Flux is classified GHS Category 4 with a LD50 cut off value 500 mg/kg body weight, after single oral administration to Wistar rats. - Executive summary:
The test item 3A-Flux administered to 3 females Wistar rats at a limit dose of 2000 mg/kg caused reaction within 30 minutes (lethargy, depression of CNS) and after two hours Animals 1 and 2 died and 4 hours after administration of test item Animal 3 died. During necropsy we observed ulcerative lesions in small intestine in all animals at this dose level.
Dose of 300 mg/kg of body weight did not caused death of animals with no signs of intoxication, change of health, or any other adverse reactions during
14-days observation period. During necropsy we did not observe any macroscopic findings in all animals at this dose level.
The body weights of all surviving animals increased in normal range during the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.